-
Weight loss drug giant Novo Nordisk collaborates with two companies on research on new therapies for cardiovascular metabolic diseases
On January 4th, Danish pharmaceutical company Novo Nordisk announced a separate research collaboration with two American biotech companies, Omega Therapeutics and Cellerity, on new therapies for card ...